List view / Grid view
3 March 2016 | By Victoria White
According to the research, a drug for a disease that affects twice as many people will generate twice the revenue. But vaccine revenue depends on finer details about how the risk is distributed in the population...
3 March 2016 | By Victoria White
ANGPTL4 inhibits lipoprotein lipase (LPL), an enzyme that helps break down triglycerides, a form of fat derived from food...
3 March 2016 | By Victoria White
Scientists at the University of Brighton have shown that bacteriophage can treat infections caused by Proteus mirabilis and prevent catheter blockage...
2 March 2016 | By Victoria White
Researchers have discovered that a GSK-J4 can kill acute lymphoblastic leukaemia that involves the TAL-1 gene...
2 March 2016 | By Victoria White
Researchers looked at the metabolism of neurons lacking DJ1 and discovered that two key metabolic pathways are affected...
2 March 2016 | By Victoria White
Cypralis, a company focussed on the discovery of novel therapeutics based on modulation of PPIases, has appointed Dr Michael Peel as Chief Scientific Officer...
2 March 2016 | By Victoria White
The US Patent 9,273,283 is the second patent of Celyad allogeneic intellectual property portfolio that is awarded by the USPTO...
1 March 2016 | By Victoria White
Using pexidartinib to flush away the inflammatory cells produced in reaction to beta-amyloid plaques, scientists restored memory function in test mice...
1 March 2016 | By Victoria White
The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval...
1 March 2016 | By Victoria White
The AChE peptide has been shown to drive production of both amyloid and hyperphosphorylated tau in Alzheimer's disease...
29 February 2016 | By Victoria White
High-resolution cryo-electron microscopy and supercomputing have now made it possible to analyse in detail the infection mechanisms of coronaviruses...
29 February 2016 | By Victoria White
Through the partnership, Lamellar hopes to gain a more detailed understanding of the biophysical properties of Lamellasomes and hence their mode of action...
29 February 2016 | By Victoria White
PeptiMimesis is a new biotech startup developing a novel class of therapeutic peptides using a breakthrough technology...
29 February 2016 | By Victoria White
ProTx-II, a peptide toxin found within the venom of the Peruvian green velvet tarantula, has a high potency and selectivity to inhibit the pain sensation receptor...
26 February 2016 | By Victoria White
Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing...
